Study: Cardiac risks higher after SARS-CoV-2 infection than mRNA vaccination
Cardiac complications after SARS-CoV-2 infection or mRNA COVID-19 vaccination are low overall but higher after infection than after vaccination, according to an analysis of electronic health record data from 40 health care systems released today by the Centers for Disease Control and Prevention. The authors said the findings support continued use of the Pfizer and Moderna COVID-19 vaccines for all eligible people aged 5 and older.
Related News Articles
Headline
The Department of Health of Human Services Aug. 21 issued a request for information seeking feedback on immunization categories within the Aug. 10 executive…
Headline
For the 2025-2026 school year, exemptions from one or more vaccines among U.S. kindergartners was at 4.2%, increasing from 3.6% for the previous school year,…
Headline
The Department of Health and Human Services June 30 announced it will terminate emergency use authorization declarations for certain drugs and medical devices…
Headline
The Centers for Disease Control and Prevention Feb. 19 released a report on the low use of COVID-19 antiviral drugs among individuals age 65 and older, a…
Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…